Home / Stocks / CRNX

CRNX insider trading

Crinetics Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-04-10Knight Jeff E.
Chief Dev. & Operating Officer
Sold85,163$40.10$3.4M
2025-06-16Betz Stephen F.
Chief Scientific Officer
Sold97,483$32.23$3.1M
2024-09-30Wilson Marc
CFO
Sold25,000$51.11$1.3M

See CRNX on the chart

Every insider buy and sell for CRNX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.